Improving access to medicines: lessons from 10 years of drug reforms in China, 2009–2020

China initiated its healthcare reform in 2009 to provide accessible and affordable healthcare to all. We summarised China’s drug reforms between 2009 and 2020 using the WHO framework. China has initiated comprehensive drug policies to address different issues, including: (1) issuing or amending majo...

Descripción completa

Detalles Bibliográficos
Autores principales: Mao, Wenhui, Jiang, Hongli, Mossialos, Elias, Chen, Wen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Practice
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9639057/
https://www.ncbi.nlm.nih.gov/pubmed/36332928
http://dx.doi.org/10.1136/bmjgh-2022-009916

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9639057/
https://www.ncbi.nlm.nih.gov/pubmed/36332928
http://dx.doi.org/10.1136/bmjgh-2022-009916

Ejemplares similares